“Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) With PF-Pembrolizumab”. Voprosy onkologii 70, no. 6 (January 22, 2025): 1096–1105. Accessed October 15, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/6-24-Toxicity.